Existing data sources in clinical epidemiology: The Scandinavian Thrombosis and Cancer Cohort

Clinical Epidemiology

Volumn 7, Issue , 2015, Pages 401-410

  Jensvoll, Hilde ^a,b   Severinsen, Marianne T ^c,d   Hammerstrøm, Jens ^e   Brækkan, Sigrid K ^a,b   Kristensen, Søren R ^c,d   Cannegieter, Suzanne C ^f   Blix, Kristine ^a,b   Tjønneland, Anne ^g   Rosendaal, Frits R ^a,f   Dziewiecka, Olga ^a   Overvad, Kim ^c,h   Næss, Inger Anne ⁱ   Hansen, John Bjarne ^a,b  

^a UNIVERSITY OF TROMSØ   (Norway)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^c AALBORG UNIVERSITY HOSPITAL   (Denmark)

^d AALBORG UNIVERSITY   (Denmark)

^e NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^f LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^g DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^h AARHUS UNIVERSITY   (Denmark)

ⁱ TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cancer; Incidence rates; Person years; Population based cohort; Prospective; Pulmonary embolism; Venous thromboembolism

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD SAMPLING; CANCER INCIDENCE; CANCER REGISTRY; COHORT ANALYSIS; DISEASE SURVEILLANCE; EPIDEMIOLOGICAL DATA; FEMALE; FOLLOW UP; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PHYSICAL EXAMINATION; RISK ASSESSMENT; RISK FACTOR; SCANDINAVIA; VENOUS THROMBOEMBOLISM;

EID: 84941945330     PISSN: None     EISSN: 11791349     Source Type: Journal    
DOI: 10.2147/CLEP.S84279     Document Type: Article

References (24)

1. Timp JF, Braekkan SK, Versteeg HH, Cannegieter SC. Epidemiology of cancer-associated venous thrombosis. Blood. 2013;122(10): 1712–1723.
2. Horsted F, West J, Grainge MJ. Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis. PLoS Med. 2012;9(7):e1001275.
3. Heit JA, O’Fallon WM, Petterson TM, et al. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med. 2002;162(11):1245–1248.
4. Cushman M, Tsai AW, White RH, et al. Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. Am J Med. 2004;117(1):19–25.
5. White RH. The epidemiology of venous thromboembolism. Circulation. 2003;107(23 Suppl 1):I4–I8.
6. Lyman GH, Khorana AA, Kuderer NM, et al; American Society of Clinical Oncology Clinical Practice. Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31(17):2189–2204.
7. Severinsen MT, Kristensen SR, Overvad K, Dethlefsen C, Tjonneland A, Johnsen SP. Venous thromboembolism discharge diagnoses in the Danish National Patient Registry should be used with caution. J Clin Epidemiol. 2010;63(2):223–228.
8. Jacobsen BK, Eggen AE, Mathiesen EB, Wilsgaard T, Njolstad I. Cohort profile: the Tromso Study. Int J Epidemiol. 2012;41(4):961–967.
9. Krokstad S, Langhammer A, Hveem K, et al. Cohort profile: the HUNT study, Norway. Int J Epidemiol. 2013;42(4):968–977.
10. Tjønneland A, Olsen A, Boll K, et al. Study design, exposure variables, and socioeconomic determinants of participation in diet, cancer and health: a population-based prospective cohort study of 57,053 men and women in Denmark. Scand J Public Health. 2007;35(4):432–441.
11. Larsen IK, Småstuen M, Johannesen TB, et al. Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer. 2009;45(7):1218–1231.
12. Storm HH, Michelsen EV, Clemmensen IH, Pihl J. The Danish Cancer Registry – history, content, quality and use. Dan Med Bull. 1997;44(5): 535–539.
13. Braekkan SK, Mathiesen EB, Njolstad I, Wilsgaard T, Stormer J, Hansen JB. Mean platelet volume is a risk factor for venous thromboembolism: the Tromso Study, Tromso, Norway. J Thromb Haemost. 2010;8(1):157–162.
14. Naess IA, Christiansen SC, Romundstad P, Cannegieter SC, Rosendaal FR, Hammerstrom J. Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost. 2007;5(4):692–699.
15. Severinsen MT, Kristensen SR, Johnsen SP, Dethlefsen C, Tjonneland A, Overvad K. Smoking and venous thromboembolism: a Danish follow-up study. J Thromb Haemost. 2009;7(8):1297–1303.
16. Storm HH, Kejs AM, Engholm G, et al. Trends in the overall survival of cancer patients diagnosed 1964–2003 in the Nordic countries followed up to the end of 2006: the importance of case-mix. Acta Oncol. 2010;49(5):713–724.
17. Heit JA. Venous thromboembolism: disease burden, outcomes and risk factors. J Thromb Haemost. 2005;3(8):1611–1617.
18. Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet. 1999; 353(9159):1167–1173.
19. Tsai AW, Cushman M, Rosamond WD, Heckbert SR, Polak JF, Folsom AR. Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. Arch Intern Med. 2002;162(10):1182–1189.
20. Silverstein MD, Heit JA, Mohr DN, Petterson TM, O’Fallon WM, Melton LJ 3rd. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med. 1998;158(6):585–593.
21. Engholm G, Ferlay J, Christensen N, et al. NORDCAN: Cancer Incidence, Mortality, Prevalence and Survival in the Nordic Countries, Version 6.1 (25.04.2014). Association of the Nordic Cancer Registries. Danish Cancer Society; 2014. Available from http://www.ancr.nu. Accessed October 20, 2014.
22. Hvidtfeldt UA, Lange T, Andersen I, et al. Educational differences in postmenopausal breast cancer – quantifying indirect effects through health behaviors, body mass index and reproductive patterns. PLoS One. 2013;8(10):e78690.
23. Braaten T, Weiderpass E, Kumle M, Lund E. Explaining the socioeconomic variation in cancer risk in the Norwegian Women and Cancer Study. Cancer Epidemiol Biomarkers Prev. 2005;14(11 pt 1): 2591–2597.
24. Cancer Registry of Norway [homepage on the Internet]. Cancer Registry dynamic databases. Available from: http://www.kreftregisteret.no/en/. Accessed August 12, 2015.